These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22788404)

  • 1. Improvement of glycemic control using methylphenidate treatment of apathy: a preliminary report.
    Padala PR; Padala KP; Sullivan DH; Reynolds DW; Desouza CV; Potter JF; Burke WJ
    J Am Geriatr Soc; 2012 Jul; 60(7):1383-4. PubMed ID: 22788404
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylphenidate for apathy and functional status in dementia of the Alzheimer type.
    Padala PR; Burke WJ; Shostrom VK; Bhatia SC; Wengel SP; Potter JF; Petty F
    Am J Geriatr Psychiatry; 2010 Apr; 18(4):371-4. PubMed ID: 20220576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The law of diminishing intent: getting excited about apathy.
    Porsteinsson AP; Hasselberg MJ
    J Clin Psychiatry; 2013 Aug; 74(8):817-8. PubMed ID: 24021499
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylphenidate Treats Apathy in Alzheimer Disease.
    Slomski A
    JAMA; 2021 Dec; 326(21):2120. PubMed ID: 34874434
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylphenidate for Apathy in Alzheimer Disease-Why Should We Care?
    Fredericks C
    JAMA Neurol; 2021 Nov; 78(11):1311-1313. PubMed ID: 34570178
    [No Abstract]   [Full Text] [Related]  

  • 6. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.
    Scherer RW; Drye L; Mintzer J; Lanctôt K; Rosenberg P; Herrmann N; Padala P; Brawman-Mintzer O; Burke W; Craft S; Lerner AJ; Levey A; Porsteinsson A; van Dyck CH;
    Trials; 2018 Jan; 19(1):46. PubMed ID: 29347996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of neuronal integrity with methylphenidate treatment for apathy in Alzheimer's disease.
    Padala PR; Padala KP; Samant RS; James GA
    Int Psychogeriatr; 2020 Apr; 32(4):539-540. PubMed ID: 32019622
    [No Abstract]   [Full Text] [Related]  

  • 8. Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Padala PR; Padala KP; Lensing SY; Ramirez D; Monga V; Bopp MM; Roberson PK; Dennis RA; Petty F; Sullivan DH; Burke WJ
    Am J Psychiatry; 2018 Feb; 175(2):159-168. PubMed ID: 28945120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.
    Rosenberg PB; Lanctôt KL; Drye LT; Herrmann N; Scherer RW; Bachman DL; Mintzer JE; ADMET Investigators
    J Clin Psychiatry; 2013 Aug; 74(8):810-6. PubMed ID: 24021498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
    Herrmann N; Rothenburg LS; Black SE; Ryan M; Liu BA; Busto UE; Lanctôt KL
    J Clin Psychopharmacol; 2008 Jun; 28(3):296-301. PubMed ID: 18480686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial.
    Mintzer J; Lanctôt KL; Scherer RW; Rosenberg PB; Herrmann N; van Dyck CH; Padala PR; Brawman-Mintzer O; Porsteinsson AP; Lerner AJ; Craft S; Levey AI; Burke W; Perin J; Shade D;
    JAMA Neurol; 2021 Nov; 78(11):1324-1332. PubMed ID: 34570180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Psychostimulants for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Kishi T; Sakuma K; Iwata N
    Pharmacopsychiatry; 2020 Apr; 53(3):109-114. PubMed ID: 32000270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. My wife has moderate Alzheimer's disease. It's difficult to get her to perform even the simplest task for herself. How can I best deal with her apathy?
    Duke Med Health News; 2012 Apr; 18(4):8. PubMed ID: 22545280
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2).
    Lanctôt KL; Chen C; Mah E; Kiss A; Li A; Shade D; Scherer RW; Vieira D; Coulibaly H; Rosenberg PB; Lerner AJ; Padala PR; Brawman-Mintzer O; van Dyck CH; Porsteinsson AP; Craft S; Levey A; Burke WJ; Mintzer J; Herrmann N
    Int Psychogeriatr; 2023 Nov; 35(11):664-672. PubMed ID: 37066690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate may treat apathy independent of depression.
    Padala PR; Petty F; Bhatia SC
    Ann Pharmacother; 2005 Nov; 39(11):1947-9. PubMed ID: 16204387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for apathy in Alzheimer's disease.
    Ruthirakuhan MT; Herrmann N; Abraham EH; Chan S; Lanctôt KL
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012197. PubMed ID: 29727467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of apathy with methylphenidate.
    Padala PR; Burke WJ; Bhatia SC; Petty F
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):81-3. PubMed ID: 17308232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate treats apathy in Parkinson's disease.
    Chatterjee A; Fahn S
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):461-2. PubMed ID: 12426416
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
    Geurts AC; Lem FC
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2417; author reply 2417. PubMed ID: 15615279
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
    Rikkert MG
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2416; author reply 2416-7. PubMed ID: 15615278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.